Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Sanjiu Pharmaceutical is a prominent pharmaceutical manufacturer based in Nanchang, China, and operates as a core subsidiary of China Resources Sanjiu Medical & Pharmaceutical. The company specializes in the production of anti-infective medications, particularly cephalosporin and macrolide antibiotics, alongside a variety of Traditional Chinese Medicine (TCM) products. Its facilities are GMP-certified and support the large-scale production of oral solids and injectable formulations. As part of the 999 brand ecosystem, Jiangxi Sanjiu contributes significantly to the parent company's market leadership in the Chinese over-the-counter and prescription drug sectors. The company is integrated into the broader China Resources Group, leveraging extensive distribution networks across mainland China. It maintains a strong focus on quality control and technological innovation within the Jiangxi regional pharmaceutical cluster.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Sanjiu Pharmaceutical.